S Scholl
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Pathology and Forensic Medicine top 10%
- Breast Lesions and Carcinomas
Papers in
- Oncology 4
- HER2/EGFR in Cancer Research 2
- Cancer Treatment and Pharmacology 1
-
- Breast Cancer Treatment Studies 4
- Cancer Genomics and Diagnostics 2
- Co-authors
- Anne de la Rochefordière (4 shared papers)Philippe Broët (4 shared papers)P Pouillart (6 shared papers)Alain Fourquet (3 shared papers)Bernard Asselain (3 shared papers)Véronique Mosseri (2 shared papers)J. Durand (1 shared paper)Yann De Rycke (2 shared papers)
In The Last Decade
S Scholl
8 papers receiving 316 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 246
- Pathology and Forensic Medicine 132
- Oncology 146
- Genetics 85
- Dermatology 17
Countries citing papers authored by S Scholl
This map shows the geographic impact of S Scholl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Scholl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Scholl more than expected).
Fields of papers citing papers by S Scholl
This network shows the impact of papers produced by S Scholl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Scholl. The network helps show where S Scholl may publish in the future.
Co-authors
The 22 scholars most cited alongside S Scholl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 151 | |
| 2 | 1999 | 97 | |
| 3 | 1996 | 28 | |
| 4 | 1999 | 26 | |
| 5 | [Herceptin, a monoclonal humanized antibody anti-HER2: a major therapeutic progress in breast cancers overexpressing this oncogene?]. | 1999 | 8 |
| 6 | Ifosfamide seven-day infusion for recurrent and cisplatin refractory ovarian cancer. | 1996 | 8 |
| 7 | [Vaccination against the tumoral mammary epithelial cells expressing MUC1 mucin]. | 1997 | 3 |
| 8 | 2015 | 2 |
About S Scholl
S Scholl is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 8 papers that have together received 323 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), Cancer Genomics and Diagnostics (2 papers), HER2/EGFR in Cancer Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cancer Treatment and Pharmacology (1 paper), Genetic factors in colorectal cancer (1 paper), Cancer Research and Treatments (1 paper) and Chemotherapy-induced organ toxicity mitigation (1 paper). The work is most often cited by research in Cancer Research (246 citations), Pathology and Forensic Medicine (132 citations), Oncology (146 citations), Genetics (85 citations) and Dermatology (17 citations). S Scholl has collaborated with scholars based in France and Germany. Frequent co-authors include Anne de la Rochefordière, Philippe Broët, P Pouillart, Alain Fourquet, Bernard Asselain, Véronique Mosseri, J. Durand, Yann De Rycke, Thierry Moreau and Emmanuelle Mouret‐Fourme. Their work appears in journals such as Breast Cancer Research and Treatment, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Zeitschrift für Gastroenterologie and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.